Oklahoma 2024 2024 Regular Session

Oklahoma Senate Bill SB1639 Introduced / Bill

Filed 01/12/2024

                     
 
 
Req. No. 2988 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
2nd Session of the 59th Legislature (2024) 
 
SENATE BILL 1639 	By: Prieto 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to kratom products; ame nding 63 O.S. 
2021, Section 1-1432.4, which relates to labeling 
requirements; modifying and addin g labeling 
requirements for kratom products; and providing an 
effective date. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2021 , Section 1-1432.4, is 
amended to read as follows: 
Section 1-1432.4. A.  A vendor shall not prepare, distribute, 
sell or expose for sale any of the f ollowing: 
1.  A kratom product that is adulterated with a nonkratom 
substance.  A kratom product is adulterated with a nonkratom 
substance if the kratom product is mixed or packed with a nonkratom 
substance and that substance affects the quality or streng th of the 
kratom product to such a degree as to render the kratom product 
injurious to a consumer; 
2.  A kratom product that is contaminated with a dangerou s 
nonkratom substance.  A kratom product is contaminated with a   
 
 
Req. No. 2988 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
dangerous nonkratom substance if the kratom product contains a 
substance that is not safe for human consumption ; 
3.  A kratom product containing a level of 7 -hydroxymitragynine 
in the alkaloid fraction that is greater than two percent (2%) of 
the alkaloid composition of the product; 
4.  A kratom product containing any synthetic alkaloid including 
synthetic mitragynine, synthetic 7 -hydroxymitragynine or any other 
synthetically derived compounds of the kratom plant; or 
5.  A kratom product containing any controlled substance listed 
in the Uniform Controlled Dangerous Substances Act, unless the 
product is compounded by a licensed pharmacist with the controlled 
substance dispensed in accordance wit h a valid prescription. 
B.  Kratom products shall be accompanied by a label, or a quick 
response (QR) code on the product label linked to a website, bearing 
the following information prior to its sale in this state: 
1.  A list of the ingredients , which shall include the common or 
usual name of each ingredient used in the manufacture of the 
product, listed in descending order of predominance; 
2.  That the sale or transfer of kratom to a person under 
eighteen (18) years of age is prohibited; 
3.  The amount of mitragynine and 7-hydroxymitragynine contained 
in the product; 
4.  The amount of mitragyni ne and 7-hydroxymitragynine contained 
in packaging for the product;   
 
 
Req. No. 2988 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
5.  The name and the principal street address of the vendor or 
the person responsible for distrib uting the product; 
6.  The suggested Clear and adequate directions for the 
consumption of and safe and effective use of the product, including 
the recommended serving size, the number of servings in the 
container, the number of servings that can be safely con sumed in a 
day, and the time frame within which safe consumption should occur ; 
and 
7.  Any precautionary statements as to the safety and 
effectiveness of the product , including a warning that a consumer 
should consult his or her physician on questions abou t use of kratom 
and a statement that the kratom product is not intended to 
“diagnose, treat, cure, or prevent any disease ”; and 
8.  A statement that a kratom product label is prohibited from 
making any therapeutic claims unless approved by the United State s 
Food and Drug Administration . 
C.  A vendor may not distribute, sell or expose for sale a 
kratom product to an individual under eighteen (18) years of age. 
D.  Upon request by the State Department of Health, the vendor 
shall provide test results from a United States-based testing 
facility to confirm the items listed on the product l abel. 
SECTION 2.  This act shall become effective November 1, 2024. 
 
59-2-2988 DC 1/12/2024 5:48:14 PM